This topic contains a solution. Click here to go to the answer

Author Question: In twin studies the key comparison involves determining how many pairs of twins either have the same ... (Read 120 times)

swpotter12

  • Hero Member
  • *****
  • Posts: 527
In twin studies the key comparison involves determining how many pairs of twins either have the same disorder or are free of the disorder; this involves the calculation of
 
  a. discordance rates.
  b. concordance rates.
  c. shared environment rates.
  d. nonshared environment rates.

Question 2

Similar concordance rates for a given trait in monozygotic (MZ) and dizygotic (DZ) twins suggests that the trait may be due to
 
  a. genetic causes.
  b. endocrine causes.
  c. environmental causes.
  d. phonotypical causes.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

diana chang

  • Sr. Member
  • ****
  • Posts: 288
Answer to Question 1

Answer: b.

Answer to Question 2

Answer: c.




swpotter12

  • Member
  • Posts: 527
Reply 2 on: Jun 22, 2018
YES! Correct, THANKS for helping me on my review


amandalm

  • Member
  • Posts: 306
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Persons who overdose with cardiac glycosides have a better chance of overall survival if they can survive the first 24 hours after the overdose.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library